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The shift in asthma prevalence from male to female predominance during the pubertal 39 
years is believed to result from an increased incidence amongst girls, rather than remission 40 
amongst boys [1,2].  Moreover, from the pubertal years onward, airway hyperresponsiveness, 41 
a classic feature of asthma, also worsens amongst girls but improves in boys [3].  Asthma 42 
medication use, a proxy for asthma severity, follows a similar pattern, with females requiring 43 
greater medication from puberty onward [2,4]. 44 
These observations support the potential involvement of sex-specific factors with 45 
asthma during this period. But, all physical changes of pubertal development cannot be 46 
considered equally in relation to asthma, particularly amongst girls.  Menarche appears to 47 
play a substantial role in asthma presence and timing of onset.  Early menarche predicts 48 
poorer lung function [5] and higher post-menarchal asthma incidence [6] compared to 49 
average/late menarchal age.     50 
To better understand the associations between puberty and asthma, we aimed to assess 51 
associations between pubertal staging and asthma symptoms and treatment in a longitudinal, 52 
population-based cohort of Swedish children (‘BAMSE’) born in 1994-96 [7].  The original 53 
cohort of 4089 infants was representative of the study catchment area, except higher rates of 54 
parental smoking amongst non-responders [7].  Participant characteristics did not differ 55 
between those followed through Year 12 and those lost to attrition [8]. At Years 8 and 12, 56 
parents completed questionnaires on wheeze frequency in the previous 12 months and asthma 57 
medication.  Subjects were deemed to have asthma based on parental reports of ≥4 episodes 58 
of wheeze or ≥1 episode of wheeze in combination with inhaled corticosteroid use in the past 59 
12 months.  Pubertal incidence of asthma was defined as no asthma at Year 8, but asthma at 60 
Year 12. At Year 12, children completed pubertal development questions, based on the 61 
composite pubertal scoring system the Peterson index [9, unpublished information from AC 62 
Peterson].  Data were collected on 3 measures for both boys and girls (skin changes, linear 63 
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growth spurt, pubic hair growth), 2 measures for boys (voice change, beard growth) and 2 64 
measures for girls (breast development, menarche).  This scoring system permits for the 65 
inclusion of the multiple characteristics of pubertal development along a continuum.  For 66 
boys, all characteristics contributed equally.  Girls reporting menarche by Year 12 were 67 
considered to be in late- or post puberty, regardless of other characteristics.  Participants were 68 
then categorized into one of five mutually exclusive categories: pre-, early-, mid-, late- or 69 
post puberty.   We further considered menarche independent of pubertal staging.   70 
We used binomial logistic regression to analyse these data and report odds ratios 71 
(OR) and corresponding 95% confidence intervals (CI) for  unadjusted analyses and models 72 
adjusted for confounding by age at Year 12. Analyses were performed with STATA 11.0 73 
(StatCorp LP, College Station, TX, USA). Permission for this study was obtained from the 74 
Regional Ethical Review Board of the Karolinska Institutet, Stockholm, Sweden.     75 
At Year 12, the response rate was 82% (3366/4089), with asthma status available for 76 
99% (3339/3366).  We excluded those for whom pubertal data were unavailable.  This 77 
yielded a sample of 2721   (67% of the original cohort), of whom 50.2% were boys..  Nearly 78 
all boys (1347/1378; 97.8%) were in pre-, early- or mid-puberty.  Nearly half of girls 79 
(651/1368; 47.6%) were in late- or post-puberty.  Thus, we created sex-specific pubertal 80 
staging categories.  Boys were trichotomized into pre-, early- or mid/late puberty (none 81 
reported post puberty).  Girls were trichotomized as pre/early-, mid- or late/post puberty.  82 
Approximately half (47.6%) of girls reported menarche by Year 12.  Compared to boys, girls 83 
had a lower odds of asthma at each assessment (e.g. Year 8: OR 0.66; 95%CI 0.47-0.92; Year 84 
12: OR 0.57; 95% CI 0.42-0.78).   85 
Pubertal staging was not found to be associated with asthma presence vs. absence in 86 
boys (Table).  In contrast, girls being late/post puberty was inversely associated with asthma 87 
at Year 12 (OR 0.35; 95% CI 0.16-0.78).  Amongst girls only, the odds of pubertal incidence 88 
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of asthma vs. asthma at neither Year 8 nor Year 12 decreased with more advanced pubertal 89 
staging (mid-puberty: OR 0.36; 95% CI 0.15-0.88; late/post puberty: OR 0.25; 95% CI 0.09-90 
0.68).  Menarche and asthma presence at Year 12 (OR 0.58; 95%CI 0.33-1.02), and menarche 91 
and pubertal incidence of asthma (OR 0.56; 95% CI 0.26-1.19) followed a similar trend, 92 
although these results did not reach statistical significance.  In neither sex was pubertal 93 
staging associated with asthma medication use at Yr12. 94 
The widely accepted sex shift in asthma prevalence during adolescence [1,2] was not 95 
noted in BAMSE  through Year 12.  Rather, pubertal incidence of asthma was lower amongst 96 
girls than boys (3.0% vs. 5.2%, p<0.01), and indeed lower in girls in late/post puberty vs. 97 
early puberty.  Our results are contrary to others’ findings, including a report of a null 98 
association between pubertal staging and asthma remission or incidence amongst similar-99 
aged youth [10].  However, their null findings may be partly explained by the low number of 100 
participants in late puberty at baseline [10].    101 
We are the first to report on the association between pubertal staging and asthma 102 
using a composite and validated measure of puberty classified into one of three mutually 103 
exclusive categories.  Others have reported on puberty [1]] and timing of menarche [5,6] and 104 
asthma.   One other group has considered multiple pubertal characteristics in their 105 
classification of pubertal staging [10].  However, they considered puberty as a binary 106 
outcome: early vs. late puberty [10].  Inclusion of a third category in our establishment of 107 
pubertal staging gleans further insight into the understanding of the progression through 108 
puberty on asthma presence and incidence during the pubertal years.  This provided the 109 
opportunity to better elucidate the associations between asthma and puberty than earlier 110 
studies. 111 
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In conclusion, we found an inverse association between puberty and asthma 112 
prevalence and incidence for girls only.  .  Follow-up at Year 16 will glean further insight 113 
into these associations as more children reach late- and post-puberty.  114 
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Table. Logistic Regression of Cross-Sectional Associations between Pubertal Staging and Asthma Presence and Pubertal Incidence at 157 
Year 12 158 
Pubertal Stage Asthma Presence vs. Absence at Yr12 Pubertal Incidence of Asthma* 
  Presence Absence Unadjusted Adjusted† Incidence No Asthma Unadjusted Adjusted† 
Boys n n OR 95% CI OR 95% CI n n OR 95% CI OR 95% CI 
Pre-puberty 28 321 1.00 1.00 16 303 1.00 1.00 
Early puberty 59 535 1.26 0.79-2.02 1.16 0.71-1.90 36 496 1.37 0.75-2.52 1.37 0.73-2.57 
Mid/late puberty 28 395 0.81 0.47-1.40 0.67 0.36-1.25 12 368 0.62 0.29-1.33 0.61 0.26-1.46 
Girls             
Pre/early puberty 13 148 1.00 1.00 9 136 1.00 1.00 
Mid-puberty  28 523 0.61 0.31-1.21 0.54 0.27-1.09 14 502 0.42 0.18-1.00 0.36 0.15-0.88‡ 
Late/post puberty  26 617 0.48 0.24-0.96‡ 0.35 0.16-0.78§ 14 576 0.37 0.16-0.87‡ 0.25 0.09-0.68‡ 
Menarche 
  
        
  
        
No 41 671 1.00 1.00 23 644 1.00 1.00 
Yes 26 617 0.69 0.42-1.14 0.58 0.33-1.02 15 579 0.67 0.34-1.32 0.56 0.26-1.19 
*Asthma incidence from Yr8 to Yr12 vs. no asthma at either Yr8 or Yr12 
†Adjusted for age at Yr12 
‡p<0.05 
            §p<0.01 
             159 
